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Since first described in 1987,
enteroaggregative  Escherichia coli (EAEC)
have been recognized increasingly as agents of
diarrhea in developing countries and (more
recently) in industrialized countries. We
review the data supporting the pathogenicity of
EAEC, discuss clinical and epidemiologic
features, and summarize the current status of
EAEC pathogenesis research.
History
E. coli have been implicated as agents of
diarrheal disease since the 1920s (1). In 1979,
Cravioto et al. reported that most enteropatho-
genic E. coli (EPEC) adhered to HEp-2 cells in
culture and that the adherence phenotype could
be used to differentiate EPEC. Subsequently,
many  E. coli not of EPEC serogroups were also
found to adhere to semiconfluent HEp-2 cells, but
the adherence phenotype was clearly different
from that induced by EPEC (2,3). Whereas the
adherence pattern of EPEC was localized, the
non-EPEC pattern was diffuse. The diffuse
adherent strains were later subdivided into two
further phenotypic subcategories: aggregative
and true “diffuse” (4). Only the aggregative were
associated with pediatric diarrhea in Santiago,
Chile (4), prompting the investigators to propose
two independent categories: EAEC and diffusely
adherent E. coli. At the same time, non-EPEC,
HEp-2 adherent strains (termed enteroadherent E.
coli) were associated with pediatric and traveler’s
diarrhea in Mexico (5,6). These enteroadherent
strains were later found to belong to the EAEC or
diffusely adherent E. coli categories (7).
Thus, EAEC are now defined as E. coli that do
not secrete heat-labile or heat-stable enterotoxins
and adhere to HEp-2 cells in an aggregative (AA)
pattern (Figure 1). This definition may encompass
both pathogenic and nonpathogenic clones that
share a factor(s) conferring a common phenotype.
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Enteroaggregative Escherichia coli (EAEC), an increasingly recognized cause of
diarrhea in children in developing countries, has been particularly associated with
persistent diarrhea (more than 14 days), a major cause of illness and death. Recent
outbreaks implicate EAEC as a cause of foodborne illness in industrialized countries. The
pathogenesis of EAEC infection is not well understood, but a model can be proposed in
which EAEC adhere to the intestinal mucosa and elaborate enterotoxins and cytotoxins,
which result in secretory diarrhea and mucosal damage. EAEC’s ability to stimulate the
release of inflammatory mediators may also play a role in intestinal illness.
Figure 1. Aggregative pattern of adherence in the
HEp-2 assay after 3 hours incubation of bacteria with
HEp-2 cells. Note bacteria on the surface of the HEp-
2 cells as well as on the glass substratum.252 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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Pathogenesis
Histopathology
EAEC strains adhere to the mucosal
epithelium of gnotobiotic piglets in a thick
mucus-containing blanket, irrespective of whether
or not the strain induces diarrhea in this animal
(8; Nataro, unpub. obs.; Figure 2). In these
studies, the intestinal epithelium displayed
pitting of goblet cells, suggesting stimulation of
mucus secretion. EAEC strains adhered to
sections of pediatric small bowel mucosa in an in
vitro organ culture (IVOC) model (9); the bacteria
were also embedded within a mucus-containing
biofilm. Two further observations support a role
of mucus in EAEC pathogenesis: EAEC bound
rabbit mucus avidly in an in vitro model (10) and
volunteers fed EAEC strains excrete mucoid
stools (11). The formation of a heavy mucus
biofilm may contribute to EAEC  diarrheagenicity
and, perhaps, to its ability to cause persistent
colonization and diarrhea.
In addition to forming the characteristic mucus
biofilm, many EAEC strains induce cytotoxic effects
on the intestinal mucosa. Infection with EAEC
strains in rabbit and rat ileal loop models resulted
in a destructive lesion demonstrable by light
microscopy (7). EAEC induced shortening of the
villi, hemorrhagic necrosis of the villous tips, and a
mild inflammatory response with edema and
mononuclear infiltration of the submucosa.
Transmission electron microscopy showed normal
microvillar architecture and no invasion of
enterocytes; both light and electron microscopy
showed adherent bacteria without the attaching
and effacing lesion, which is characteristic of EPEC.
Mucosal damage has also been demonstrated
in ileum specimens taken after patients died of
EAEC persistent diarrhea during an outbreak in
the malnutrition ward of Mexico City Hospital
(12). This effect was reproduced in the IVOC
model; EAEC induced exfoliation of enterocytes
from the mucosal surface of pediatric intestinal
biopsies (9). Indeed, EAEC strains elicit cytotoxic
effects on T84 cells (human intestinal carcinoma)
in vitro (13;  Figure 3). In the in vitro model,
EAEC induced the microvillar membrane to
vesiculate and the cells from the monolayer to
exfoliate. This effect was accompanied by
increased vacuole formation and separation of
the nucleus from the surrounding cytoplasm.
Damage was most prominent in areas where
EAEC were adhering to the cells. In both the T84
and IVOC systems, the toxic effects required
genes encoding the adherence fimbriae (14), as
well as other genes on the 65MDa plasmid.
Adherence
Adherence of EAEC to the intestinal mucosa
has been well studied. A flexible, bundle-forming
EAEC fimbrial structure 2 nm to 3 nm in
diameter, designated aggregative adherence
fimbriae I (AAF/I) (15), mediates HEp-2
adherence and human erythrocyte hemaggluti-
nation in EAEC strain 17-2. The genes for AAF/I
are organized as two separate gene clusters on
the 60 MDa plasmid separated by 9 kb of
intervening DNA (16-18). Region 1 genes encode
the fimbrial structure itself; nucleotide sequence
analysis of the Region 1 cluster suggests that
Figure 2. Biofilm (arrow), containing aggregating
bacteria and mucus, adhering to the mucosa of a
gnotobiotic piglet fed enteroaggregative E. coli strain
042 and sacrificed after 3 days. This piglet did not
contract diarrhea. (Reprinted with permission of
James Nataro and Clinical Microbiology Reviews.
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AAF/I is related to the Dr family of adhesins (18).
Region 2 genes encode a transcriptional activator
of AAF/I expression (AggR), which is a member of
the AraC family of DNA binding proteins (17).
The AAF/I fimbriae are bundle-forming fimbriae
but do not show homology with members of the
so-called type 4 class of fimbriae (19).
A second fimbrial structure, designated AAF/
II, has been identified (14); it is distinct from but
related to AAF/I. Insertional mutants in AAF/II
genes no longer adhered to colonic mucosa in
IVOC. DNA probe analysis suggested that AAF/I
and AAF/II were each present in only a minority
of EAEC strains and thus, as is the case with
enterotoxigenic E. coli, intestinal colonization of
EAEC appears to be mediated by one or more of
several different fimbrial antigens.
In some EAEC strains, AA may be due to
factors other than the AAF fimbriae (20,21). An
afimbrial outer membrane protein or a 38 kDa
outer membrane protein may be responsible for
AA in some strains (20,21).
EAEC ST-Like Toxin
Savarino et al. have identified an open reading
frame encoding a 4,100 Da homologue of the heat-
stable enterotoxin designated EAST1 (22,23),
which is a 38-amino acid protein featuring four
cysteine residues, instead of six (which are
characteristic of E. coli ST). A role for EAST1 in
human disease has not been demonstrated,
although EAST1 clones yield net increases in short
circuit current in the rabbit mucosal Ussing
chamber model (22). Of the four strains given to
volunteers, one that induced diarrhea, as well as
one that did not, secreted EAST1 (11).
EAST1 has been found in approximately 40%
of EAEC strains and in a similar proportion of
nonpathogenic E. coli strains (24). Other E. coli
categories, most notably EHEC, elaborate EAST1
with a higher frequency than EAEC (24).
Invasiveness
Some EAEC strains may invade intestinal
epithelial cells in vitro (25). However, human
intestinal explants do not internalize EAEC, and
clinical evidence for or against a role for
invasiveness is lacking (9).
Other EAEC Toxins
In an outbreak of EAEC diarrhea in Mexico,
Eslava et al. identified (in serum from patients in
the outbreak) an approximately 108 kDa protein
that induces exfoliation of enterocytes in the rat
ileal loop model. DNA sequence analysis of the
plasmid-borne gene (C. Eslava, J. Czeczulin, F.
Navarro-Garcia, I. Henderson, A. Cravioto, J.P.
Nataro, unpub. obs.) encoding this protein
suggests that the toxin is a member of the family
of proteins (26) called autotransporters because
their secretion through the bacterial outer
membrane is mediated by the carboxy terminus
of the molecule. The 108 kDa toxin (termed Pet for
plasmid-encoded toxin) also induces enterotoxic
activity from rat intestinal tissue mounted in the
Ussing chamber (F. Navarro-Garcia, C. Eslava,
Figure 3. Effects of enteroaggregative E. coli strain
042 on T84 cells in culture. Polarized T84 monolayers
were washed and inoculated with 106 CFU of 042 and
allowed to coincubate at 37°C for 6 hrs. Transmission
electron microscopy reveals adherence of bacteria to
the apical surface of the T84 cells without
internalization. The apical brush border is effaced;
cells are ballooning and will eventually be extruded
from the monolayer. (J.P. Nataro and S. Sears, unpub.
data). Bar, 1 mm.254 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
Synopses
J.P. Nataro, A. Cravioto, unpub. obs.). A 120
kDa EAEC supernatant protein had been
described that elicited rises in intracellular
calcium in HEp-2 cells (27). Whether or not this
protein is related to the protein described by
Eslava et al. remains to be determined.
Intestinal Inflammation
An ongoing study of infant diarrhea in
Fortaleza, Brazil (28-30), has shown that
children with EAEC infection have intestinal
inflammation, as measured by the presence of
inflammatory markers in the stool (31). These
markers include lactoferrin, a stable neutrophil
product and sensitive marker for fecal neutro-
phils; interleukin-8 (IL-8), a neutrophil
chemokine; and interleukin-1b (IL-1b), a
polyfunctional proinflammatory cytokine. Fecal
lactoferrin, IL-8, and IL-1b were elevated in
children with persistent diarrhea due to EAEC but
not in controls (children in the same cohort without
stool pathogens and free of diarrhea for 3 weeks
before and after the time of the stool sample in
prospective surveillance). Fecal lactoferrin and IL-
1b were also elevated in children with EAEC but no
diarrhea for 3 weeks. The origin of these
inflammatory factors remains unknown, although
they may be the result of direct stimulation of
cytokine release from the epithelium.
While studying cytokine release in vitro,
Steiner et al. observed IL-8 release from Caco-2
intestinal epithelial cells exposed to cell-free
filtrates of EAEC strains 042 or 17-2. This release
was apparently mediated by a heat-stable, high
molecular weight, chromosomally encoded protein
(31). Lipopolysaccharide does not appear respon-
sible for this effect as it is not blocked by polymyxin
B and is not elicited by normal E. coli flora.
The relationship between IL-8 release and
the symptoms of EAEC infection is not known,
especially since severe infiltration by neutrophils
has not yet been reported in EAEC histopatho-
logic specimens. However, a hypothetical role for
IL-8 release in EAEC diarrhea can be envisioned.
IL-8 released from epithelial cells in response to
EAEC could act as the first step in a secretory
cascade by recruiting neutrophils, since neutro-
phils in the intestinal epithelium release 5'-
adenosine monophosphate, which is converted by
a 5'-nucleotidase on the apical surface of
enterocytes to adenosine, an agonist for chloride
secretion (32). A similar mechanism of neutrophil
chemotaxis and cytokine release may also be
involved in the diarrhea produced by other
microbial products, such as Clostridium difficile
toxin A (33,34).
Strain Heterogeneity
EAEC strains exhibit considerable heteroge-
neity. Studies at the University of Maryland
found that at a dose of 1010 CFU with bicarbonate,
strain 042 (which produces AAF/II fimbriae,
EAST1, and the 108 kDa Pet toxin) elicited loose
stools in 4 of the 5 adult volunteers (11). Three
other strains, all of which expressed AAF/I and
one of which secreted EAST1, did not produce any
intestinal symptoms. These data suggest that
virulence is likely to be heterogeneous and that
Pet may play an important role.
A Model of EAEC Pathogenesis
Extrapolating from the observations de-
scribed above, we propose a three-stage model of
EAEC pathogenesis. Stage I involves initial
adherence to the intestinal mucosa and the
mucus layer; this initial adherence is apparently
mediated by the AAF fimbriae. Stage II comprises
enhanced mucus production, apparently leading to
the deposit of a thick mucus-containing biofilm
encrusted with EAEC. The blanket may
promote persistent colonization and nutrient
malabsorption. Stage III,  suggested from
histopathologic and molecular evidence, in-
cludes the elaboration of toxins or inflamma-
tion, which result in damage to the mucosa and
intestinal secretion. Malnourished hosts may
be unable to repair the mucosal damage and
may thus become prone to the persistent
diarrhea syndrome.
The site of EAEC infection in the human
intestine has yet to be clearly demonstrated.
IVOC experiments have shown that EAEC
strains can adhere to both small and large bowel
mucosa (9). Tissue specimens in these studies
were derived from pediatric patients and were
not formalin-fixed before they were incubated with
EAEC strains. These features may explain the
discrepant results obtained by other investigators
(35,36). The short incubation period observed in
some humans challenged with strain 042 (as short
as 8 hours) is also consistent with involvement of
the small bowel in diarrheagenicity (11).
Clinical Features
The clinical features of EAEC diarrhea are
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cases, and the volunteer model. Typical illness is
manifested by a watery, mucoid, secretory
diarrhea with low grade fever and little to no
vomiting (37,38). However, up to one-third of
patients with EAEC diarrhea have had grossly
bloody stools (39); this outcome may be strain
dependent. In volunteers infected with EAEC
strain 042, the diarrhea was mucoid, of low
volume, and without occult blood or fecal
leukocytes; all patients remained afebrile. In
such volunteers, the incubation period of the
illness was 8 to 18 hours (11).
The duration of EAEC diarrhea is its most
striking feature. In a community surveillance
study in Anapur-Palla in northern India, the
mean duration of EAEC-associated diarrhea
cases in children under 3 years of age was 17
days, longer than that associated with any other
pathogen (37). In this study, of the 41 cases of
diarrhea, fever was found in 12%, gross blood in
12%, vomiting in 7%, and persistence of the
episode more than 14 days in 44%.
A large percentage of patients excreting
EAEC have detectable fecal lactoferrin and
supranormal levels of IL-8 in the stool (31).
Although this observation suggests that EAEC
infection may be accompanied by mucosal
inflammation, most patients lack overt clinical
evidence of inflammation.
Diagnosis
EAEC colonization is detected by isolating E.
coli  from stool samples and demonstrating the
AA pattern in the HEp-2 assay. Analysis of small
bowel aspirates has not increased yield (40).
Implication of EAEC as the cause of the patient’s
disease must be done cautiously, given the high
rate of asymptomatic colonization in many
populations (4,30,41-43). If no other organism is
implicated in the patient’s illness and EAEC is
isolated repeatedly, it may be considered to be a
probable cause of the patient’s illness.
Despite various methods of performing the
HEp-2 assay (4,44,45), comparative studies
suggest that the technique first described by
Cravioto et al. (45,46) (i.e., a single 3-hour
incubation of bacteria with cells, without a change
in medium during the assay) best discriminates
among the three adherence patterns. Because AAF
adhesins are expressed maximally in static L-broth
cultures at 37°C (15), we incubate all HEp-2 assay
inocula in this manner.
A DNA fragment probe has proven highly
specific in detecting EAEC strains. This probe
was developed by Baudry et al. (47), who tested
fragments derived empirically from the plasmids
of strains 17-2 and 042. A 1.0 kb plasmid-derived
Sau3a fragment hybridized with 56 (89%) of 63
EAEC strains (defined by HEp-2 assay); of 376
strains representing normal flora and other
diarrheagenic categories, only 2 hybridized with
the probe. The correlation of the EAEC probe-
positivity with AA varies by location. In some
studies, the correlation achieves the 89%
sensitivity reported by Baudry et al. (47,48),
while in other studies, the sensitivity may be
substantially lower (40). The epidemiologic
significance of probe-positive versus probe-
negative strains has not been determined. The
nucleotide sequence of the AA probe represents a
cryptic open reading frame adjacent to the
plasmid replicon (J.P. Nataro, unpub. obs.). A
polymerase chain reaction assay using primers
derived from the AA probe sequence shows
similar sensitivity and specificity (49).
Epidemiology
Volunteer studies and outbreak investiga-
tions have shown that at least some EAEC strains
are human pathogens. A growing number of
studies have supported the association of EAEC
with diarrhea in developing countries; the
increasing number of such reports and the rising
proportion of diarrheal cases in which EAEC are
implicated suggest that EAEC are important
emerging agents of pediatric diarrhea.
EAEC in Sporadic Diarrhea
The earliest epidemiologic reports showed
that EAEC were most prominently associated
with persistent (lasting >14 days) cases of
pediatric diarrhea (Table 1). In some of these
studies, EAEC cultured from the stool during the
first few days of diarrhea were predictive of a
longer illness (37,43).
The importance of EAEC in diarrheal disease
appears to vary geographically. On the Indian
subcontinent, six studies (which included hospi-
talized patients with persistent diarrhea [50],
outpatients visiting health clinics [51], and cases
of sporadic diarrhea detected on household
surveillance [37]) have demonstrated the impor-
tance of EAEC in pediatric diarrhea
(37,38,48,50,51,53).256 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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Table 1. Epidemiologic studies associating enteroaggregative Escherichia coli (EAEC) with diarrhea ( p < 0.05)
Source or EAEC  in cases
reference Syndrome Site vs controls Comments
4 All diarrhea Santiago, Chile 84(33%)/253 vs Community and hospital-based.
20(15%)/134a First description of EAEC
37 Persistent diarrhea Anapur-Palla, India 18(30%)/61 vs. Household surveillance of rural
20(10%)/201b children £3 yrs; first association
of EAEC with PD
50 Persistent diarrhea New Delhi, India 18(20%)/92 vs Case-control study of nonbloody
6(7%)/92b PD in children £ 2 yrs
28 Persistent diarrhea Fortaleza, Brazil 8(20%)/40 vs. Household surveillance of
2(5%)/38b children £ 5 yrs
39 All diarrhea; Morales, Mexico 78(12%)/636a Household surveillance of
persistent diarrhea and 29(51%)/57b children £ 2 yrs
vs 5(5%)/100
43 Persistent diarrhea Mirzapoor, 17(27%)/62 vs Household surveillance of
Bangladesh 5(18%)/28c children £  6 yrs.  EAEC isolated
in first 2 days of episode
predicts persistence
29 Persistent diarrhea Fortaleza, Brazil 8(20%)/40 vs Outpatients £ 29 months with PD
2(5%)/38b
51 All diarrhea New Delhi, India 9(21%%)/42 vs Children £ 4 yrs referred to
4(4%)/107b hospital
38 Acute diarrhea Calcutta, India 17(11%)/159 vs EAEC associated with acute
 3(2%)/174d secretory diarrhea in hospitalized
pediatric patients
42 All diarrhea Tehran, Iran 99(32%)/309 vs Pediatric outpatients.  High rate
17(17%)/100a of antibiotic resistance among
EAEC
39 Persistent diarrhea Fortaleza, Brazil 38(68%)/56 vs Outpatients £ 3 yrs; EAEC
13(31%)/42b associated with more cases of PD
than all other agents combined
48 Acute diarrhea Vellore, India 60(8%)/794 vs Outpatients £ 3 yrs with diarrhea
22(4%)/566a £ 3 days
52 All diarrhea Wurzberg, Germany 16(2%)/798 Hospitalized children  £ 16 yrs.
 vs 0/580a First description of EAEC
disease burden in industrialized
countries
41 Acute diarrhea Caracas, Venezuela 138(27%)/513 vs Inpatient and outpatient
36(15%)/241a children £ 2 yrs with diarrhea £ 3
days. EAEC only associated with
diarrhea in infants £  2 mos of age
Jalla- All diarrhea Lwiro, Zaire 29(25%)/115 vs Outpatients £ 5 yrs. First
  luddin et 3(8%)/34a description of EAEC
  al., 1997, in Africa
  pers. comm.
aAll diarrhea vs. asymptomatic.
bPersistent diarrhea (PD) vs. asymptomatic.
cPersistent diarrhea vs. acute diarrhea.
dSecretory vs. invasive diarrhea.257 Vol. 4, No. 2, April–June 1998 Emerging Infectious Diseases
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EAEC and persistent diarrhea syndrome
have been consistently associated (28,29,30,40).
In Brazil, EAEC have been implicated in up to
68% of persistent diarrhea cases (40), which
represent a disproportionate share of deaths due
to diarrhea. EAEC have also been implicated as
causes of sporadic diarrhea in Mexico, Chile,
Bangladesh, and Iran (4,39,42,43).
The epidemiologic characteristics of EAEC
(e.g., likely sources, reservoirs of infection, routes
of transmission, seasonality, and age-distribu-
tion) are largely unknown. Most studies in which
EAEC are implicated as causes of diarrhea have
isolated the organism from infants and small
children, yet volunteer studies and outbreak
investigations suggest that school-age children
and adults are also susceptible (54-56). Regard-
ing sources of infection, EAEC strains have been
isolated from the lacteal contents of infant
feeding bottles in Brazil (57).
Recent studies have suggested that EAEC
are found frequently in stool samples of patients
in industrialized countries and may be important
agents of diarrhea. EAEC were isolated from 2%
of pediatric patients with diarrhea in Germany;
the pathogen was associated with diarrheal
illness (58). The patients from whom EAEC were
isolated had characteristically prolonged illness,
often followed by apparent abdominal pain
mimicking infant colic.
EAEC Outbreaks
Several outbreaks of EAEC diarrhea have
now been reported (Table 2). The first detailed
description of an outbreak from which EAEC
were clearly implicated involved 19 infants in a
hospital nursery in Nis, Serbia, during 9 days in
1995 (52). Twelve of the 19 infants had the same
multidrug-resistant EAEC strain of serogroup
O4, while none of five well neonates had this
organism (p = 0.02). The illness lasted 3 to 9 days
(mean 5.2 days) in 16 babies, but in three infants,
persistent diarrhea developed, lasting 18 to 20
days. Infants with diarrhea typically had liquid
green stools. In three infants, mucus was visibly
apparent; no infant had bloody stools. All but
three infants required intravenous hydration but
all survived. The source of infection was unclear.
In two outbreaks of severe lethal diarrhea
in malnutrition wards of Mexico City hospitals
(12), persistent diarrhea developed in affected
infants, and five patients died despite aggres-
sive support. Autopsy findings from infants
who died in these outbreaks showed severe
necrotic lesions of the ileal mucosa.
During a diarrhea epidemic in a village in
southern India in January 1996, EAEC were
identified in the stools of 11 of 20 persons who
were thought to have outbreak-related diarrhea;
1 of 11 stools from asymptomatic controls from
the same village (p < 0.02) contained EAEC (59).
Intake of water from open wells was associated
with diarrheal illness; however, EAEC were not
identified from this source, and contaminated
water was not definitively implicated as the
source of the epidemic.
EAEC outbreaks also occur in industrialized
countries. In a massive outbreak of EAEC
diarrhea in Gifu Prefecture, Japan, in 1993, 2,697
children at 16 schools became ill after consuming
contaminated school lunches (54). The illness was
characterized by abdominal pain, nausea, and
severe diarrhea, which was protracted in at least
30 cases. The incubation period for this illness
averaged 40 to 50 hours. A single EAEC strain of
serotype O:H10 was implicated, but the organism
was not found in any of the foods served in the
implicated lunch.
Four outbreaks of EAEC-related diarrhea
occurred in the United Kingdom in 1994 (56),
which involved 19, 10, 51, and 53 persons,
respectively, most of them adults. Only in the last
Table 2. Outbreaks of enteroaggregative Escherichia coli diarrhea
Reference Setting Patients Illness
52 Nursery; Nis, Serbia, 1995 19 infants Watery diarrhea
56 Conference Center, UK, 1994 51 adults Watery diarrhea for 3-7 days
56 Hotel, UK, 1994 53 adults Watery diarrhea, mean duration 68 hr
59 Village in southern India, 1996 20 children Watery diarrhea, mean duration 11 days
  and adults
12 Nursery, Mexico City Not reported Severe diarrhea; 5 deaths
54 16 schools, Gifu, Japan 2,697 school Diarrhea; some cases protracted
  children258 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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two outbreaks was a single EAEC strain
implicated. Although each of these outbreaks was
linked to consumption of a meal, no single vehicle
has been implicated. The illnesses were
characterized by vomiting and diarrhea, occa-
sionally with fever. The mean duration of illness
in one outbreak was 68 hours. Strains of E. coli
O44:H18 implicated in outbreaks in the United
Kingdom (and previously presumed to be EPEC)
are in fact EAEC (55). This report mentions three
EAEC outbreaks, two among children and one
among adult patients.
EAEC and Malnutrition
Perhaps even more significant than the
association of EAEC with diarrhea may be the
recent data from Fortaleza, Brazil, that link
EAEC with growth retardation in infants (31). In
this study, EAEC isolated from the stools of
infants was associated with a low z-score for
height or weight, irrespective of the presence of
diarrheal symptoms. Such an association has
been suggested for Cryptosporidium (60). A study
among an Australian aborigine population
supports the association of EAEC with growth
retardation in the absence of diarrhea (S.
Elliott, J.P. Nataro, unpub. data). Given the
high prevalence of asymptomatic EAEC
excretion in many areas (4,30,41-43), if this
observation holds up in further studies, the
contribution of EAEC to human disease might
be much greater than is currently thought.
Conclusions
EAEC is an emerging diarrheal pathogen
linked to acute and persistent diarrhea in both
developing and industrialized countries. Both
sporadic diarrhea and outbreaks (possibly
foodborne) have been described. The mechanisms
of pathogenesis are being elucidated; likely not
all EAEC strains are equally pathogenic. The
mechanism of the association between EAEC and
malnutrition is not entirely clear, although
plausible pathogenetic models can be proposed.
Malnutrition predisposes to persistent diarrhea
(61,62); whether this is due to impaired host
immunity (preventing normal killing of patho-
gens) or to altered intestinal physiology
(predisposing to more severe infections) is not
known. However, it seems also plausible that
asymptomatic colonization with EAEC may lead
to malnutrition caused by increased metabolic
demand secondary to intestinal inflammation,
persistent mucosal damage due to cytotoxins,
and/or the presence of a barrier to the absorption
of nutrients imposed by the mucus/bacteria
biofilm. A vicious cycle may thus operate wherein
malnutrition and infection perpetuate and
enable each other (Figure 4). The pathophysi-
ologic machinery that  propels children through
Figure 4. Relationship between diarrhea and
malnutrition (31, 60–62).
this circle is probably multifactorial and opens
several possible avenues for intervention against
this important global problem.
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